Cargando…

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis

BACKGROUND: Effects of β-blockers on outcomes in patients with chronic heart failure (CHF) and atrial fibrillation (AF) is still in controversy. METHODS: Searching was conducted by using keywords “atrial fibrillation”, and “heart failure” in PubMed, MEDLINE and Embase databases before November 30, 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Tianyu, Huang, Yuli, Zhou, Haobin, Bai, Yujia, Huang, Xingfu, Hu, Yunzhao, Xu, Dingli, Zhang, Yuhui, Zhang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547467/ https://www.ncbi.nlm.nih.gov/pubmed/31159740 http://dx.doi.org/10.1186/s12872-019-1079-2

Ejemplares similares

The top tertile of hematocrit change during hospitalization is associated with lower risk of mortality in acute heart failure patients
por: Zhou, Haobin, et al.
Publicado: (2017)

Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis
por: Chen, Ying, et al.
Publicado: (2015)

Comparative effects of intensive ganglionated plexus ablation in treating paroxysmal atrial fibrillation and vasovagal syncope
por: Huang, Xingfu, et al.
Publicado: (2020)

Heart Failure Is Associated with Increased Risk of Long-Term Venous Thromboembolism
por: Xu, Tianyu, et al.
Publicado: (2021)

Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation
por: Yang, Yanhua, et al.
Publicado: (2020)

Congestive Heart Failure Exhibited Higher BMI With Lower Energy Intake and Lower Physical Activity Level: Data From the National Health and Examination Nutrition Survey
por: Xu, Tianyu, et al.
Publicado: (2021)

Triglyceride-Glucose Index and Homeostasis Model Assessment-Insulin Resistance in Young Adulthood and Risk of Incident Congestive Heart Failure in Midlife: The Coronary Artery Risk Development in Young Adults Study
por: Zeng, Xianghui, et al.
Publicado: (2022)

Beta-blockers and 1-year clinical outcomes in hospitalized heart failure patients with atrial fibrillation
por: XING, Fu-Wei, et al.
Publicado: (2021)

Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives
por: Chourdakis, Emmanouil, et al.
Publicado: (2021)

Blood pressure trajectories in early adulthood and myocardial structure and function in later life
por: Zhou, Haobin, et al.
Publicado: (2022)

Optimal antithrombotic therapy after transcatheter aortic valve replacement in patients with atrial fibrillation
por: Zeng, Qingchun, et al.
Publicado: (2020)

White-coat hypertension is a risk factor for cardiovascular diseases and total mortality
por: Huang, Yuli, et al.
Publicado: (2017)

Association between admission plasma 2-oxoglutarate levels and short-term outcomes in patients with acute heart failure: a prospective cohort study
por: Peng, Zhengliang, et al.
Publicado: (2019)

Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis
por: Huang, Yuli, et al.
Publicado: (2016)

The effect of beta-blockers on mortality in patients with heart failure and atrial fibrillation: A meta-analysis of observational cohort and randomized controlled studies
por: Ma, Gai-gai, et al.
Publicado: (2020)

Prehypertension and the Risk of Coronary Heart Disease in Asian and Western Populations: A Meta‐analysis
por: Huang, Yuli, et al.
Publicado: (2015)

Predictive value of remnant cholesterol level for all-cause mortality in heart failure patients
por: Zhao, Lang, et al.
Publicado: (2023)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
por: Ma, Haotian, et al.
Publicado: (2021)

Atrial Fibrillation and Heart Failure
por: Bergau, Leonard, et al.
Publicado: (2022)

Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis
por: Ruddox, Vidar, et al.
Publicado: (2017)

Catheter ablation and mortality, stroke and heart failure readmission with atrial fibrillation
por: Pallisgaard, Jannik Langtved, et al.
Publicado: (2020)

Relationships among achieved heart rate, β-blocker dose and long-term outcomes in patients with heart failure with atrial fibrillation
por: Miller, Robert J H, et al.
Publicado: (2016)

Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis
por: Cai, Xiaoyan, et al.
Publicado: (2020)

Prehypertension and incidence of cardiovascular disease: a meta-analysis
por: Huang, Yuli, et al.
Publicado: (2013)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
por: Habel, Nicole, et al.
Publicado: (2023)

Risk of Coronary Heart Disease in Different Criterion of Impaired Fasting Glucose: A Meta-Analysis
por: Xu, Tianyu, et al.
Publicado: (2015)

Atrial fibrillation ablation in heart failure
por: Balla, Cristina, et al.
Publicado: (2020)

Comorbidities Associated with One-Year Mortality in Patients with Atrial Fibrillation and Heart Failure
por: Horodinschi, Ruxandra Nicoleta, et al.
Publicado: (2021)

Post-mortem examination of high mortality in patients with heart failure and atrial fibrillation
por: Țica, Otilia, et al.
Publicado: (2022)

Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis
por: Karwath, Andreas, et al.
Publicado: (2021)

Association between the beta‐blockers, calcium channel blockers, all‐cause mortality and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta‐analysis of randomized controlled trials
por: Wu, Mingming, et al.
Publicado: (2023)

Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients
por: Huang, Yuli, et al.
Publicado: (2017)

Association Between TCF21 Gene Polymorphism with the Incidence of Paroxysmal Atrial Fibrillation and the Efficacy of Radiofrequency Ablation for Patients with Paroxysmal Atrial Fibrillation
por: Zhang, Xianlin, et al.
Publicado: (2022)

Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure
por: Yang, Pil-Sung, et al.
Publicado: (2021)

Atrial fibrillation and mortality in outpatients with heart failure in Tanzania: a prospective cohort study
por: Chen, Yunchan, et al.
Publicado: (2022)

Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study
por: Gómez Doblas, Juan José, et al.
Publicado: (2023)

Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
por: Naccarelli, Gerald V, et al.
Publicado: (2009)

Beta-blockers in atrial fibrillation—trying to make sense of unsettling results
por: Meyer, Markus, et al.
Publicado: (2023)

Atrial Fibrillation in Heart Failure: An Innocent Bystander?
por: Khan, MA, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lt78p6k2mc4lp88sg7cg0dpn4a